Skip to content
Menu

Sucampo Pharmaceuticals, Inc. SCMP

Full chart Compare
Set alert

Price alert · SCMP

All alert types

No live quote for SCMP yet.

Fundamental scorecard

6 of 25 checks passed on SCMP’s reported financials

ValueGrowthProfitabilityHealthDividend

6of 25 checks passed

  • Value 1 of 5
  • Growth 3 of 5
  • Profitability 1 of 5
  • Financial health 1 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2017.

Value 1 of 5

  • Failed:P/E below its own 5-year median No profit over the last 12 months, so no P/E.
  • Failed:P/E under 20 No profit over the last 12 months, so no P/E.
  • Passed:Price to sales below its own 5-year median Price to sales 3.4 against a 5-year median of 4.5.
  • Failed:Price to book below its own 5-year median Price to book 21.4 against a 5-year median of 6.8.
  • Failed:Free cash flow yield above 4% Free cash flow of 28.6M is 3.4% of the market value.

Growth 3 of 5

  • Passed:Revenue grew over the last year Revenue of 250M is +17.9% on the 12 months before.
  • Passed:Revenue grew more than 5% a year over five years +33.3% a year from FY 2011 to FY 2016.
  • Failed:Earnings per share grew over the last year EPS -3.28 against 0.29 in the 12 months before.
  • Passed:Earnings per share grew more than 5% a year over five years EPS -0.41 in FY 2011, 0.42 in FY 2016.
  • No data:Analysts expect higher earnings per share over the next year No analyst estimate.

Profitability 1 of 5

  • Failed:Profitable over the last year Net income of -151M over the last 12 months.
  • Passed:Profitable in each of the last five fiscal years A profit in 5 of the last 5 fiscal years.
  • Failed:Return on equity above 15% Return on equity of -163.6%.
  • Failed:Net margin above its 5-year average Net margin of -60.2% against a 5-year average of 11.0%.
  • Failed:Free cash flow is at least 80% of net income No profit over the last 12 months to compare with.

Financial health 1 of 5

  • Passed:Short-term assets cover short-term liabilities Short-term assets of 190M against short-term liabilities of 37.2M.
  • Failed:Short-term assets cover long-term liabilities Short-term assets of 190M against long-term liabilities of 311M.
  • Failed:Net debt under 40% of equity Net debt of 217M is 547.3% of equity.
  • Failed:Operating cash flow covers at least 20% of debt Operating cash flow of 29.0M is 9.9% of debt.
  • Failed:Operating profit covers interest at least 3 times Operating profit is -9.2 times the interest expense.

Dividend 0 of 5

  • Failed:Pays a dividend No dividend paid.
  • Failed:Yield above 1.5% No dividend paid.
  • Failed:Pays out under 75% of profit No dividend paid.
  • Failed:Covered by free cash flow No dividend paid.
  • Failed:Not cut in the last five fiscal years No dividend paid.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What SCMP owns and owes, as of Sep 30, 2017

Short term and long term

Balance sheet · 388M of assets

Debt, equity and cash by year

Now: 217M of debt after cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Valuation

P/E 0.0×
P/S 0.0×
P/B 0.0×
P/FCF 0.0×
EV/EBITDA 1.1×
EV/Sales 0.4×
FCF Yield 0.0%

Profitability

Gross Margin 67.0%
Operating Margin 23.4%
Net Margin 8.0%
ROE 11.1%
ROIC 10.9%
ROA 3.5%

Growth (YoY)

Revenue 50.2%
Operating Income 21.2%
EPS (diluted) -42.5%
Free Cash Flow -46.1%

Financial Health

Current Ratio 9.5×
Quick Ratio 8.8×
Debt / Equity 1.7×
Net Debt / EBITDA 1.1×
Interest Coverage 2.3×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2016-12-31